-
Signature
-
/s/ Paul Breaux, by Power of Attorney for Mark W. Jenkins
-
Issuer symbol
-
CVNA
-
Transactions as of
-
06 Jun 2025
-
Net transactions value
-
-$7,124,160
-
Form type
-
4
-
Filing time
-
09 Jun 2025, 19:17:27 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| JENKINS MARK W. |
Chief Financial Officer |
C/O CARVANA CO., 300 E. RIO SALADO PKWY, TEMPE |
/s/ Paul Breaux, by Power of Attorney for Mark W. Jenkins |
09 Jun 2025 |
0001700540 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CVNA |
Class A Common Stock |
Sale |
$7,000,000 |
-20,000 |
-9.4% |
$350.00 |
192,239 |
06 Jun 2025 |
Direct |
F1 |
| transaction |
CVNA |
Class A Common Stock |
Conversion of derivative security |
$0 |
+20,000 |
+10% |
$0.000000 |
212,239 |
09 Jun 2025 |
Direct |
F1, F2, F3, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CVNA |
Class B Units |
Conversion of derivative security |
$89,394 |
-18,326 |
-100% |
$4.88 |
0 |
09 Jun 2025 |
Class A Common Stock |
14,400 |
$4.88 |
Direct |
F1, F2, F3 |
| transaction |
CVNA |
Class B Units |
Conversion of derivative security |
$34,766 |
-7,127 |
-3.6% |
$4.88 |
192,873 |
09 Jun 2025 |
Class A Common Stock |
5,600 |
$4.88 |
Direct |
F1, F3, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: